SG11201609739UA - Derivatives of dolaproine-dolaisoleuine peptides - Google Patents
Derivatives of dolaproine-dolaisoleuine peptidesInfo
- Publication number
- SG11201609739UA SG11201609739UA SG11201609739UA SG11201609739UA SG11201609739UA SG 11201609739U A SG11201609739U A SG 11201609739UA SG 11201609739U A SG11201609739U A SG 11201609739UA SG 11201609739U A SG11201609739U A SG 11201609739UA SG 11201609739U A SG11201609739U A SG 11201609739UA
- Authority
- SG
- Singapore
- Prior art keywords
- dolaisoleuine
- dolaproine
- peptides
- derivatives
- dolaisoleuine peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462004084P | 2014-05-28 | 2014-05-28 | |
| PCT/US2015/032704 WO2015183978A1 (en) | 2014-05-28 | 2015-05-27 | Derivatives of dolaproine-dolaisoleuine peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201609739UA true SG11201609739UA (en) | 2016-12-29 |
Family
ID=54699722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201609739UA SG11201609739UA (en) | 2014-05-28 | 2015-05-27 | Derivatives of dolaproine-dolaisoleuine peptides |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20170190735A1 (https=) |
| EP (1) | EP3149024B9 (https=) |
| JP (3) | JP2017519740A (https=) |
| KR (1) | KR102413079B1 (https=) |
| CN (2) | CN121949442A (https=) |
| ES (1) | ES2883023T3 (https=) |
| RU (1) | RU2747989C2 (https=) |
| SG (1) | SG11201609739UA (https=) |
| WO (1) | WO2015183978A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015183978A1 (en) * | 2014-05-28 | 2015-12-03 | Agensys, Inc. | Derivatives of dolaproine-dolaisoleuine peptides |
| WO2017058808A1 (en) * | 2015-10-02 | 2017-04-06 | Sirenas Llc | Anti-cancer compounds and conjugates thereof |
| EP4321522A1 (en) * | 2022-08-12 | 2024-02-14 | Seagen Inc. | Cytotoxic compounds and conjugates thereof |
| CN120917016A (zh) * | 2023-05-06 | 2025-11-07 | 荣昌生物制药(烟台)股份有限公司 | 一种奥瑞他汀衍生物中间体的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993003054A1 (fr) * | 1991-08-09 | 1993-02-18 | Teikoku Hormone Mfg. Co., Ltd. | Nouveau derive de tetrapeptide |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US6569834B1 (en) | 1992-12-03 | 2003-05-27 | George R. Pettit | Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| JPH06234790A (ja) * | 1993-02-09 | 1994-08-23 | Teikoku Hormone Mfg Co Ltd | 新規テトラペプチドアミド誘導体 |
| EP0731106B1 (en) | 1993-10-01 | 2004-11-17 | Teikoku Hormone Mfg. Co., Ltd. | Dolastatin derivatives |
| US5530097A (en) * | 1994-08-01 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory peptide amides |
| US5521284A (en) * | 1994-08-01 | 1996-05-28 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide amides and esters |
| US5663149A (en) | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| US6323315B1 (en) | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| US20030083263A1 (en) * | 2001-04-30 | 2003-05-01 | Svetlana Doronina | Pentapeptide compounds and uses related thereto |
| US7008928B2 (en) * | 2001-09-20 | 2006-03-07 | Teikoku Hormone Mfg. Co., Ltd. | Tetrapeptide derivative TZT-1027 crystal |
| EP1675465B1 (en) | 2003-10-22 | 2010-03-03 | The Johns Hopkins University | Improved combination bacteriolytic therapy for the treatment of tumors |
| CA2572318A1 (en) * | 2004-07-02 | 2006-01-12 | Neutec Pharma Plc | Treatment of cancer |
| US8288352B2 (en) * | 2004-11-12 | 2012-10-16 | Seattle Genetics, Inc. | Auristatins having an aminobenzoic acid unit at the N terminus |
| US7608592B2 (en) | 2005-06-30 | 2009-10-27 | Virobay, Inc. | HCV inhibitors |
| CN101242816B (zh) * | 2005-06-30 | 2012-10-31 | 维罗贝股份有限公司 | Hcv抑制剂 |
| ES2708763T3 (es) * | 2005-07-07 | 2019-04-11 | Seattle Genetics Inc | Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C |
| CN101932598B (zh) | 2008-01-30 | 2016-12-21 | 皮里斯股份公司 | 具有对人c-met受体酪氨酸激酶的亲和性的泪脂质运载蛋白的突变蛋白及其获得方法 |
| DK2265283T3 (da) * | 2008-03-18 | 2014-10-20 | Seattle Genetics Inc | Auristatin-lægemiddel-linker-konjugater |
| US9120854B2 (en) * | 2008-04-11 | 2015-09-01 | Seattle Genetics, Inc. | Detection and treatment of pancreatic, ovarian and other cancers |
| BR112013027119A8 (pt) | 2011-04-21 | 2018-03-06 | Seattle Genetics Inc | novos conjugados ligante-droga (adcs) e uso dos mesmos |
| RU2566693C2 (ru) * | 2011-07-08 | 2015-10-27 | Сименс Акциенгезелльшафт | Система слоев с двухслойным металлическим слоем |
| US20130190248A1 (en) * | 2011-07-26 | 2013-07-25 | Agensys, Inc. | Substituted peptide analogs |
| CN104185477B (zh) * | 2011-11-17 | 2017-05-24 | 辉瑞公司 | 细胞毒性肽及其抗体‑药物缀合物 |
| CN104640572B (zh) * | 2012-05-15 | 2018-04-27 | 索伦托医疗有限公司 | 药物偶联物，偶联方法，及其用途 |
| KR101763499B1 (ko) * | 2012-11-07 | 2017-07-31 | 화이자 인코포레이티드 | 항-il-13 수용체 알파 2 항체 및 항체-약물 접합체 |
| CA2890571A1 (en) | 2012-11-07 | 2014-05-15 | Kenneth G. Geles | Anti-notch3 antibodies and antibody-drug conjugates |
| WO2015183978A1 (en) * | 2014-05-28 | 2015-12-03 | Agensys, Inc. | Derivatives of dolaproine-dolaisoleuine peptides |
-
2015
- 2015-05-27 WO PCT/US2015/032704 patent/WO2015183978A1/en not_active Ceased
- 2015-05-27 JP JP2016569825A patent/JP2017519740A/ja active Pending
- 2015-05-27 CN CN202610089819.2A patent/CN121949442A/zh active Pending
- 2015-05-27 SG SG11201609739UA patent/SG11201609739UA/en unknown
- 2015-05-27 RU RU2016150426A patent/RU2747989C2/ru not_active Application Discontinuation
- 2015-05-27 US US15/313,906 patent/US20170190735A1/en not_active Abandoned
- 2015-05-27 ES ES15799069T patent/ES2883023T3/es active Active
- 2015-05-27 CN CN201580041582.0A patent/CN107041139A/zh active Pending
- 2015-05-27 KR KR1020167036764A patent/KR102413079B1/ko active Active
- 2015-05-27 EP EP15799069.8A patent/EP3149024B9/en active Active
-
2019
- 2019-11-14 US US16/684,208 patent/US11312748B2/en active Active
-
2020
- 2020-05-07 JP JP2020081698A patent/JP6995160B2/ja active Active
-
2021
- 2021-12-14 JP JP2021202579A patent/JP7292366B2/ja active Active
-
2022
- 2022-03-18 US US17/698,353 patent/US12612429B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3149024A1 (en) | 2017-04-05 |
| EP3149024B1 (en) | 2021-05-12 |
| CN107041139A (zh) | 2017-08-11 |
| EP3149024A4 (en) | 2018-06-06 |
| CN121949442A (zh) | 2026-05-01 |
| ES2883023T3 (es) | 2021-12-03 |
| RU2016150426A3 (https=) | 2018-12-20 |
| WO2015183978A1 (en) | 2015-12-03 |
| JP2022027896A (ja) | 2022-02-14 |
| US20200325170A1 (en) | 2020-10-15 |
| JP2020128405A (ja) | 2020-08-27 |
| JP6995160B2 (ja) | 2022-01-14 |
| KR20170005495A (ko) | 2017-01-13 |
| JP7292366B2 (ja) | 2023-06-16 |
| RU2747989C2 (ru) | 2021-05-18 |
| JP2017519740A (ja) | 2017-07-20 |
| US20170190735A1 (en) | 2017-07-06 |
| RU2016150426A (ru) | 2018-07-03 |
| US11312748B2 (en) | 2022-04-26 |
| KR102413079B1 (ko) | 2022-06-24 |
| US20220204557A1 (en) | 2022-06-30 |
| US12612429B2 (en) | 2026-04-28 |
| EP3149024B9 (en) | 2021-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201706729SA (en) | Derivatives of sobetirome | |
| SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
| GB201418562D0 (en) | Peptides | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PL3418273T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL248773A0 (en) | History of naphthyridinedione | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| GB201401877D0 (en) | Peptides | |
| SG11201608634RA (en) | Cycloalkyl-linked diheterocycle derivatives | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| SMT201900438T1 (it) | Nuovi derivati di cyp-eicosanoide | |
| SG11201609739UA (en) | Derivatives of dolaproine-dolaisoleuine peptides | |
| GB201503483D0 (en) | Novel Antimmicrobial Peptides | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| GB201410686D0 (en) | Peptides | |
| IL249332A0 (en) | Crystalline forms of sofosbuvir | |
| GB201504211D0 (en) | Use of peptides | |
| GB201420645D0 (en) | Peptides | |
| GB201412731D0 (en) | Peptides | |
| GB201409010D0 (en) | Peptides | |
| GB201405078D0 (en) | Peptides | |
| GB201415235D0 (en) | Trans-locating peptide | |
| GB201404910D0 (en) | Trans-locating peptide | |
| GB201412797D0 (en) | Proteins |